Australia Últimas notícias

Reece (ASX:REH) has announced a $50 million increase to its on-market share buyback, lifting the total target to $85 million.

Shares in data centre operator NEXTDC (ASX:NXT) rose 7% by midday on Dec. 22 following the announcement of new customer contract wins.

Health Canada has approved Neuren Pharmaceuticals' (ASX:NEU) clinical trial application for the Koala Phase 3 clinical trial.

Southern Australian states are expected to rely heavily on Queensland's surplus gas to meet demand by the second quarter of 2026.

Clarity Pharmaceuticals (ASX:CU6) received positive guidance from the US FDA to proceed with a pivotal Phase 3 trial of its 64Cu-SARTATE diagnostic agent in patients with neuroendocrine tumours.

Worley (ASX:WOR) has been awarded the construction and fabrication contract for Suncor Energy's Firebag Debottleneck Project.

Pure One Corporation (ASX:P1E) has entered into a binding term sheet to sell its entire 40% equity interest in Turquoise Group.

Nick Scali (ASX:NCK) has upgraded its sales and profit forecasts for the first half of FY26 after reporting stronger-than-expected trading in Australia and New Zealand.

Dimerix (ASX:DXB) confirmed that BioMarin Pharmaceutical (NASDAQ:BMRN) entered into a definitive agreement to acquire its US commercial licensing partner, Amicus Therapeutics (NASDAQ:FOLD)

Seven West Media (ASX:SWM), the parent company of Network Seven, is set to be delisted from the Australian Securities Exchange after investors approved a takeover by Southern Cross Media (ASX:SXL).

IVE Group (ASX:IVE) has signed a binding agreement to acquire 100% of Daily Press, an Australian creative agency.

DroneShield (ASX:DRO) announced a series of governance and policy changes following an independent review.